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Objectives. We hypothesized that modulation of atrioventricu- 
lar (AV) node conduction, allowing a reduction in ventricular rate 
during atrial fibrillation or flutter without affecting AV conduction 
during sinus rhythm, might be achieved through ablation of the 
"slow" AV node pathway. 
Background. In patients with atrial fibrillation or flutter not 
amenable toa direct atrial approach, ablation of the His bundle is 
performed to induce complete AV block. This procedure causes 
pacemaker dependence. 
Methods. Fourteen patients with drug-refractory paroxysmal 
atrial flutter or fibrillation underwent ablation of the slow AV 
node pathway. Radiofrequency current was delivered in six pa- 
tients during sinus rhythm, in six during atrial flutter and in two 
during atrial fibrillation. 
Results. The anterograde effective refractory period of the AV 
node was prolonged from 270 +- 50 (mean -+ SD) to 390 -+ 87 ms 
(p = 0.005) and the Wenckebach cycle from 346 -+ 33 to 458 -+ 
75 ms (p = 0.004) in six patients during sinus rhythm. Mean AV 
ratio increased from 1.6 + 0.5 to 3.0 + 0.6 (p = 0.02) in six 
patients with atrial flutter. Mean ventricular rate decreased from 
157 -+ 38 to 67 -+ 10 beats/rain in two patients with atrial 
fibrillation. Complete AV block was induced in two patients 
(transient in one, permanent in one). During a follow-up eriod of 
5.8 -+ 3.5 months, 11 patients experienced a recurrence of atrial 
fibrillation at 60 to 95 beats/rain. No patient had progression to 
any degree of AV block. 
Conclusions. Ablation of the slow AV node pathway allows 
reduction of ventricular rate during atrial fibrillation or flutter 
while maintaining intact AV conduction during sinus rhythm. 
Modulation of AV node conduction is effective in most patients as 
an alternative to His bundle ablation for control of ventricular 
rate in paroxysmal trial fibrillation or flutter. 
(J Am CoU Cardiol 1995;25:39-46) 
Patients with drug-refractory atrial fibrillation or flutter are 
currently considered candidates for transvenous ablation of the 
His bundle for the purpose of inducing complete atrioventric- 
ular (AV) block (1-3). However, the resulting pacemaker 
dependence r presents he major drawback of the procedure, 
particularly in patients with paroxysmal rrhythmias in whom a 
physiologic AV activation sequence would be desirable during 
sinus rhythm. 
Direct atrial ablation allows successful termination of typi- 
cal atrial flutter with a low incidence of short-term recurrence 
(4-6). However, most patients with atrial flutter have struc- 
tural heart disease, which, in association with atypical atrial 
flutter or atrial fibrillation, is less likely to lead to successful 
long-term results because of extensive pathologic hanges in 
the atria (7,8). 
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In this setting a modification of AV node conduction 
properties, aimed at a reduction of ventricular rate during 
atrial fibrillation or flutter, could be beneficial. Further- 
more, to be clinically useful the procedure should allow 
regular AV conduction during sinus rhythm. Electrophysi- 
ologic studies (9) of AV node conduction after selective 
radiofrequency atheter ablation of either the "fast" or the 
"slow" AV node pathway have shown a prolonged antero- 
grade effective refractory period and Wenckebach cycle 
after ablation of the slow pathway, without changes in the 
AH interval during sinus rhythm. By contrast, although 
ablation of the fast pathway prolongs the AH interval, it 
does not change the Wenckebach cycle and the refractory 
period of the AV node (9). 
These data support he hypothesis that the "slow" pathway 
plays an important role in AV conduction at fast rates and 
constitute the rationale for it as a target for ablation to achieve 
modulation of AV node conduction. 
This study evaluates the immediate results and short-term 
follow-up data of slow AV node pathway ablation to control 
ventricular ate in patients with drug-refractory paroxysmal 
atrial fibrillation or flutter. 
© 1995 by the American College of Cardiology 0735-1097/95/$9.50 
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Table 1. Clinical Characteristics of the 14 Study Patients 
Age Underlying Max HR 
Pt No./Gender (yr) Disease Presenting Atrial Arrhythmia (beats/min) Symptoms 
I/M 60 CAD Atrial flutter + fibrillation 145 Angina 
2/F 69 Mitral prothesis Atrial tachycardia + fibrillation 230 Acute pulmonary edema 
3/M 63 Hypertension Atrial flutter + fibrillation 160 Palpitations 
4/F 45 Mitral prothesis Atrial flutter + fibrillation 250 Syncope 
5/M 65 Hypertension Atrial flutter + fibrillation 170 Acute pulmonary edema 
6/M 36 None Atrial flutter + fibrillation 140 Palpitations 
7/M 48 None Atrial flutter + fibrillation 135 Palpitations 
8/M 40 None Atrial fibrillation 185 Palpitations 
9/M 52 DCM Atrial flutter* 150 Acute pulmonary edema 
10/F 40 HPCM Atrial flutter + fibrillation 150 Syncope 
l I/F 69 Hypertension Atrial tachycardia + fibrillation 190 Angina, dizziness 
12/M 57 Mitroaortic disease Atrial fibrillation 145 Acute pulmonary edema 
13/1= 60 Operation for ASD Atrial flutter + fibrillation 140 Palpitations 
14/F 68 Hypertension Atrial fibrillation 160 Palpitations, dizziness 
*Two types of flutter. ASD = atrial septal defect; CAD - coronary artery disease; DCM = dilated cardiomyopathy; F = female; HPCM = hypertrophic 
cardiomyopathy; M - male; Max HR - maximal heart rate; Pt - patient. 
Methods  
Patients. The study included 14 patients (8 men, 6 women; 
36 to 69 years old, mean [+_SD] age 55.1 _+ 11.5) with recurrent 
drug-refractory paroxysmal trial tachycardia, flutter or fibril- 
lation, leading to severe symptoms ( yncope in two; pulmonary 
edema in four; angina, dizziness and palpitations in eight). In 
all patients multiple types of arrhythmias (e.g., different con- 
figurations of atrial flutter or fibrillation and flutter) were 
documented for each patient at different times. For this reason 
the patients included in the study were not considered candi- 
dates for direct atrial ablation. Mean left atrial size was 49 _+ 
8 mm (range 36 to 65); mean left ventricular ejection fraction 
was 47 _+ 9% (range 20% to 55%). The clinical characteristics 
of the patients are summarized in Table 1; details of therapy 
are presented in Table 2. 
Electrophysiologic procedures. All patients were sedated 
by an intravenous bolus of morphine and diazepam; invasive 
arterial blood pressure and oxygen saturation were continu- 
ously monitored throughout the procedure. Multipolar elec- 
trode catheters were positioned in the right atrium, right 
ventricle and coronary sinus and across the tricuspid ring to 
record the His bundle electrogram. An additional 4-mm 
tip-deflectable catheter was placed over the tricuspid ring to 
perform mapping of the right atrial posteroseptal region and 
for later ablation. Multiple surface electrocardiographic 
(ECG) leads and intracavitary tracings were simultaneously 
recorded on a Siemens T 16 polygraph at a paper speed of 
200 mm/s; electrical stimulation was provided by a Medtronic 
5320 Programmable Stimulator. 
The following variables were analyzed at baseline and after 
ablation: anterograde effective refractory period of the AV 
node and the Wenckebach cycle (in six patients in sinus 
rhythm); AV conduction ratio and maximal heart rate during 
atrial flutter or tachycardia (six patients); and mean ventricular 
rate over a 30-min period in the two patients with atrial 
fibrillation. Furthermore, in six patients in whom ablation was 
performed uring sinus rhythm, the AV conduction ratio or 
maximal heart rate was evaluated uring atrial flutter or 
tachycardia or during atrial fibrillation induced after the 
procedure. 
Ablation procedure. Ablation performed during sinus 
rhythm in six patients, atrial flutter or tachycardia n six and 
atrial fibrillation in the remaining two. Radiofrequency current 
was delivered in the unipolar mode between the ablation 
catheter tip and an electrodispersive skin patch placed poste- 
riorly, using a radiofrequency generator providing 550-kHz 
unmodulated energy (American Cardiac Ablation Company, 
model Liz 88). The applied voltage ranged from 40 to 60 V; 
impedance was continuously monitored by meter, and mean 
values ranged from 90 to 110 ohms; the resulting power was 15 
to 30 W; pulses duration was 15 to 60 s. Energy delivery was 
discontinued if an impedance increase >120 ohms was ob- 
served. 
The target for ablation of the slow AV node pathway during 
sinus rhythm was a high frequency potential, closely following 
low amplitude atrial activation, preceding the His bundle 
deflection by 35 _+ 12 ms (range 20 to 50) (Fig. 1), occurring 
synchronously or later than atrial activity recorded in the 
proximal coronary sinus, as previously described by Jackman et 
al. (10) for ablation of AV junctional tachycardia. Mean slow 
pathway potential ventricular electrogram ratio was 0.75:1 
(range 0.6:1 to 1:1). This potential was usually recorded in the 
low posterior septum (Fig. 2), slightly anterior to the coronary 
sinus os. Induction of a junctional rhythm with 1:1 ventricu- 
loatrial (VA) conduction was considered a criterion of efficacy 
(10,11). Radiofrequency energy was interrupted if no junc- 
tional rhythm ensued within 10 s. When junctional rhythm 
occurred, energy was delivered for 30 to 45 s, until disappear- 
ance of the junctional rhythm. The catheter was then moved, in 
the same region, to record a similar potential, and energy was 
again delivered until the appearance of a junctional rhythm 
could be documented. The procedure was repeated several 
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Table 2. Therapy, Maximal Documented Heart Rate and Related Symptoms Before and After Ablation 
Before Ablation After Ablation 
Max HR Max HR 
Pt No. Therapy (beats/min) Symptoms Therapy (beats/rain) Symptoms 
1 Quinidine, disopyramide, flecainide, 145 Angina Flecainide (50 mg hid) 90 - -  
amiodarone, verapamil, digoxin 
2 Flecainide, metoprolol, verapamil, 230 Acute pulmonary edema Digoxin (0.125 mg die) 76 - -  
digoxin 
3 Flecainide, metoprolol 160 Palpitations Captopril (50 mg die) - -  - -  
4 Propafenone, flecainide, metoprolol, 250 Syncope Sotalol (60 mg bid) 85 Palpitations 
sotalol, amiodarone 
5 Quinidine, disopyramide, flecaioide, 170 Acute pulmonary edema Captopril (50 mg die) 70 Palpitations 
verapamil, digoxin 
6 Propafenone, flecainide, sotalol, 140 Palpitations - -  - -  - -  
amiodarone, verapamil 
7 Disopyramide, propafenone, 135 Palpitations - -  90 - -  
flecainide, amiodarone, verapamil 
8 Metoprolol, sotalol, amiodarone, 185 Palpitations Nadolol (20 mg bid) 75 - -  
verapamil 
9 Fleeainide, amiodarone, verapamil, 150 Acute pulmonary edema Digoxin (0.25 mg die) 90 - -  
digoxin 
10 Metoprolol, amiodarone, verapamil 150 Syncope Flecainide (50 mg bid) 70 Palpitations 
11 Quinidine, disopyramide, 190 Angina, dizziness Enalapril (20 mg die) 70 - -  
propafenone, amiodarone, 
verapamil 
12 Amiodarone, verapamil, digoxin 145 Acute pulmonary edema Digoxin (0.125 mg die) 60 - -  
13 Disopyramide, flecainide, verapamil 140 Palpitations - -  - -  - -  
14 Quinidine, disopyramide, 160 Angina, dizziness - -  80 - -  
propafenone, verapamil 
bid : twice a day; die - daily; other abbreviations a in Table 1. 
times in each patient (range 5 to 15) before undertaking 
measurement of AV node conduction properties by pro- 
grammed atrial stimulation or overdrive pacing. Although 
target values for AV node refractoriness or Wenckebach point 
were not defined, the effort was made to modify the AV 
conduction ratio so as to avoid 1:1 conduction at paced rates 
> 120 beats/rain. 
When the procedure was performed uring atrial flutter or 
tachycardia, mapping of the same area was performed to 
record an electrogram, characterized byatrial activity includ- 
ing a high frequency spike (Fig. 3). This probably cannot be 
considered a recording of the slow pathway potential, but it can 
be used to localize the base of the triangle of Koch. Several 
radiofrequency pulses were delivered with the goal of obtain- 
ing a stable increase in AV conduction ratio. 
In the two patients with atrial fibrillation, selection of the 
ablation site was guided by anatomic markers, with the abla- 
tion catheter placed anteriorly to the coronary sinus os, 1 to 
1.5 cm below the His bundle, to record the irregular activity of 
atrial fibrillation with the highest possible amplitude. An initial 
increase followed by a sustained slowing of the ventricular rate 
after the onset of radiofrequency delivery (Fig. 4) was consid- 
ered evidence of ablation of the slow pathway. Several current 
pulses were delivered at closely surrounding places until a 
permanent slowing of the heart rate was achieved. 
All patients were monitored for 1 h in the electrophysi- 
ologic laboratory to ensure stability of the results. Isoprotere- 
nol (1 to 3 pg/min) was infused in three patients in whom a 
stable 4:1 AV conduction pattern was induced after ablation to 
ensure capability to increase ventricular rate on sympathetic 
stimulation. Echocardiography was performed immediately 
after the procedure and on the following day. 
Patient follow-up. Patients were discharged from the hos- 
pital 4 to 6 days after the procedure; during the hospital stay 
they were monitored by telemetry. Aspirin (325 mg daily) was 
prescribed for 2 months; digoxin or beta-adrenergic blocking 
agents were prescribed when needed in patients who had been 
taking the same therapy before ablation. Details of therapy are 
reported in Table 2. After discharge, an outpatient clinic visit 
was scheduled at 1 month and then at 2-month intervals. A 
standard ECG and a 24-h Holter ECG were obtained at each 
visit. Patients were also requested to record an ECG in the 
event of palpitations. 
Statistical methods. Results are expressed as mean value 
_+ SD. A Student t test was used to assess the significance of the 
observed changes in the refractory period and Wenckebach 
cycle. 
Resu l ts  
Electrophysiologic data. Detailed values of the AV node 
refractory period, Wenckebach cycle, AV ratio and mean 
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Figure 1. Simultaneous recordings of six standard surface electrocar- 
diographic leads and multiple intracavitary electrograms (Patient 3). 
Arrow points to the potential used to localize the slow atrioventricular 
node pathway ablation site during sinus rhythm. In the tricuspid 
annulus recorded through the distal electrode pairs of the catheter 
(TAd), a sharp spike follows low amplitude atrial activity; the spike 
occurs 30 ms before the His bundle deflection. Paper speed 200 mm/s. 
d (p) = distal (proximal) electrode pairs of the catheter; HBE = His 
bundle electrogram; HRA = high right atrium; RVA = right ventric- 
ular apex. 
ventricular ate before and after ablation are presented in 
Table 3. In six patients the procedure was performed uring 
sinus rhythm, thus allowing evaluation of the changes in AV 
node physiology. The anterograde ffective refractory period 
increased from 270 _+ 50 to 390 _+ 87 ms (p = 0.005) and the 
Wenckebach cycle from 346 + 33 to 458 + 75 ms (p = 0.004). 
An episode of atrial flutter or fibrillation was induced at the 
end of the procedure in all six patients, documenting a marked 
decrease in ventricular rate during the arrhythmia. The mean 
number of radiofrequency pulses was 10.7 + 4.0 in this group 
of patients. When radiofrequency was delivered during atrial 
flutter (Fig. 5) or tachycardia (six patients), the AV conduction 
ratio increased from 1.6 _+ 0.5 to 3.0 _+ 0.6 (p = 0.02); maximal 
heart rate decreased from 172 _ 53 to 93 _+ 26 beats/rain (p = 
0.04). The mean number of radiofrequency pulses to achieve 
this result was 8.2 _+ 2.6. In one patient (Patient 6) no changes 
in AV ratio were observed after three radiofrequency pulses 
delivered to the posteroseptal region. The ablation catheter 
was moved slightly superiorly, closer to the His bundle record- 
ing site. Complete AV block occurred within 4 s of radiofre- 
quency delivery, and despite the recovery of a temporary 4:1 
AV conduction pattern, complete AV block ensued 12 h later, 
HIS 
Figure 2. Schematic illustration of the triangle of Koch. Hatched area 
represents he posterior part of the septum, where the slow pathway 
potential was recorded and radiofrequency energy was delivered to 
achieve modulation of the atrioventricular (AV) conduction. Stars 
indicate the sites where complete AV block (transient in one patient 
and permanent in the other) was induced. CS = coronary sinus; His = 
His bundle; IVC = inferior vena cava; TI" = tendon of Todaro; TV = 
tricuspid valve. 
and a permanent ventricular ate-responsive (VVIR) pace- 
maker was implanted. Temporary complete AV block was also 
induced in a second patient (Patient 14) in whom the proce- 
dure was initially performed uring sinus rhythm. The delivery 
of radiofrequency pulses caused an increase in the effective 
refractory period from 230 to 320 ms and a prolongation of the 
Wenckebach cycle from 340 to 380 ms. However, the ventric- 
ular rate during atrial fibrillation induced afterward was 130 to 
140 beats/rain. Sinus rhythm could not be recovered after two 
direct current shocks in this patient. Additional radiofrequency 
pulses were delivered uring atrial fibrillation in an attempt o 
reduce ventricular esponse. However, complete AV block 
resulted after the third radiofrequency pulse, delivered 1.5 cm 
posterior to the His bundle recording site, with resumption, 2 
Figure 3. Arrow indicates the electrogram recorded at the ablation site 
in a patient during atrial flutter (Patient 1). A distinct spike follows 
local atrial activation. Paper speed 200 mm/s. Abbreviations as in 
Figure 1. 
II 
I I I  
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Figure 4. Effects of radiofrequency 
energy pulse targeted on the "slow" 
atrioventricular node pathway dur- 
ing atrial fibrillation in Patient 14. 
The ablation site in this patient was 
selected by means of anatomic land- 
marks. Top, A marked shortening of
the RR cycle is observed 3 s after 
current delivery. Bottom, After 30 s 
from onset of radiofrequency deliv- 
ery, mean ventricular cycle is pro- 
longed to 1,060 ms (shown in lead 
II). Mean ventricular rate in the fol- 
lowing 30-rain period ranged from 
60 to 70 beats/rain. Paper speed 50 
mm/s. HRA = high right atrium. 
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days later, of sinus rhythm with a 1:1 AV conduction ratio. A 
VVIR pacemaker was subsequently implanted for safety rea- 
sons. In-hospital ECG monitoring revealed constant normal 
AV conduction (PQ interval 160 ms) and a recurrence of atrial 
fibrillation with a ventricular rate of 60 to 65 beats/min. 
Despite problems with reliable evaluation of ventricular 
rate in the setting of atrial fibrillation, mean ventricular rate, 
calculated over a 30-rain period, decreased from 157 + 38 to 
67 _+ 10 beats/min after 9.5 _+ 4.9 radiofrequency pulses in the 
two patients (Patients 8 and 12) with this arrhythmia. A 
transient increase in ventricular rate, followed by a late persis- 
tent slowing, was considered a marker of successful slow 
pathway ablation. 
At termination of the procedure, sinus rhythm was 
present in 8 of 14 patients, and the AH interval was normal 
in four patients (Patients 1, 2, 3 and 5) and slightly 
prolonged in four (Patients 4, 10, 11 and 13). However, in 
three of the latter patients (Patients 10, 11 and 13), the AH 
interval was unaffected by the procedure. In the remaining 
patient (Patient 4), ablation was performed during atrial 
flutter, and baseline control AH values are not available; the 
PR interval during sinus rhythm remained unchanged with 
respect o preablation tracings. Mean fluoroscopic time was 
39 +_ 9 min. 
In-hospital monitoring. All patients were monitored by 
telemetry for 4 to 6 days after the procedure. Regular sinus 
rhythm was documented in all patients without disturbances of
AV conduction, with the exception of Patient 6 who had a 
permanent pacemaker implanted 2 days after ablation. Recur- 
rences of atrial arrhythmia were documented, either by telem- 
etry or by Holter recording, in seven patients (Patients 1, 4, 7, 
9, 11, 12 and 14) at a variable rate from 60 to 95 beats/rain. The 
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Table 3. Electrophysiologic Features Before and After Ablation 
Max HR* Wenkebach Cycle A l l  Interval 
AV Ratio (beats/min) (ms) ERP (ms) (ms) 
No. of Rx Time 
Pt No. Presenting Arrhythmia Pulses (rain) Before After Before After Before After Before After Before After 
1 Atrial flutter 6 50 2:1 3-4:1 135 90 . . . .  80 80 
2 Atrial tachycardia 8 36 1-2:1 3-4:1 230 76 . . . .  80 80 
3 Sinus rhythm 6 33 2:1 4:1 160 80 350 400 220 350 60 60 
4 Atrial flutter 10 53 1-2:1 4:1 250 62 . . . . .  140 
5 Sinus rhythm 9 21 2:1 4:1 120 60 300 410 250 340 60 60 
6 Atrial flutter 3 + 1 37 2:1 2:1 140 140 . . . . .  CAVB 
7 Atrial flutter 9 51 2:1 3-4:1 130 90 . . . . . .  
8 Atrial fibrillation 6 30 - -  - -  185' 75* . . . . . .  
9 Atrial flutter 5 50 2:1 3:1 150 100 . . . . . .  
10 Sinus rhythm 15 37 - -  - -  150 95 340 460 290 340 130 130 
11 Sinus rhythm 13 42 2:1 4:1 190 70 360 550 290 520 110 110 
12 Atrial fibrillation 13 39 - -  - -  130" 60* . . . . . .  
13 Sinus rhythm 6 31 - -  - -  140 80 400 550 350 480 100 100 
14 Sinus rhythm + atrial fibrillation 9 +3# 48 - -  - -  160' 140" 340 380 230 320 80 CAVB~ +
*Mean heart rate (HR) over a 30-min period in patients with atrial fibrillation. ?Number of pulses during atrial fibrillation. :~Transient complete atrioventricular 
(AV) block (CAVB). ERP = effective refractory period; Pt = patient; Rx = treatment. 
echocardiogram obtained the day after each procedure re- 
mained unchanged, without signs of pericardial effusion. 
Follow.up. All patients were followed up at the outpatient 
clinic at 1 month and then at 2-month intervals after ablation 
for a mean of 5.8 _+ 3.5 months (range 2 to 12). Recurrences, 
either symptomatic or asymptomatic, of atrial tachycardia, 
flutter or fibrillation were documented in 11 of 14 patients 
(Patients 1, 2, 4, 5, 7 to 12 and 14) during the follow-up period. 
Three patients (Patients 4, 5 and 10) had paroxysms of 
palpitations, and all three had documented recurrence ofatrial 
fibrillation with a ventricular rate of 75 -+ 8 beats/min. These 
patients had presented with syncope (Patients 4 and 10) or 
acute pulmonary edema (Patient 5) that did not recur at 
follow-up. In the remaining eight patients, short-duration 
asymptomatic atrial tachycardia, trial flutter or atrial fibrilla- 
tion with a ventricular rate of 78 _+ 10 beats/min was docu- 
mented during Holter monitoring or scheduled follow-up 
visits. A follow-up exercise ECG was obtained uring atrial 
fibrillation in two patients (Patients 8and 12); peak heart rate 
was 120 and 125 beats/min respectively. In no patient was there 
progression to high grade AV block. 
Discuss ion  
The results of this study support he possibility of modula- 
tion of AV conduction by radiofrequency ablation of the "slow 
pathway." The procedure is feasible in most patients and 
allows a substantial reduction in ventricular rate during atrial 
tachycardia, flutter or fibrillation without affecting AV conduc- 
tion during sinus rhythm. 
Modulation versus ablation of A¥ junction. Radiofre- 
quency ablation of the AV junction for the purpose of inducing 
a permanent, complete AV block is effective, but results in 
lifetime pacemaker dependence (1-3), This represents the 
major limitation of the procedure in patients with paroxysmal 
arrhythmias nd results in loss of the physiologic AV activation 
sequence during sinus rhythm. The possibility of slowing the 
ventricular rate during atrial fibrillation without affecting con- 
duction during sinus rhythm--modulation of AV conduction-- 
was initially investigated by Duckeck et al. (12), by delivery of 
graded radiofrequency energy to the anterior egion of the 
interatrial septum, close to the His bundle recording site. The 
end point of the procedure was a 50% increase in AH interval 
or a prolongation of the Wenckebach cycle to 400 ms. The 
results were disappointing because of a high rate of immediate 
or late AV block and low clinical efficacy during follow-up. It 
was thought that modulation of AV conduction could not be 
achieved in a reproducible fashion and was related to nonspe- 
cific damage to the AV node-His bundle conduction system. 
However, ablation of the slow pathway has more recently been 
shown to effectively reduce ventricular ate during spontane- 
ous (13,14) or induced (15) atrial fibrillation, without causing 
complete AV block. 
Is there always a "slow AV node pathway"? The results of 
the present study are not surprising in view of the changes in 
AV node conduction that occurred after selective radiofre- 
quency catheter ablation of the "slow pathway," as previously 
described in patients with AV junctional tachycardia (9). In 
these patients, the presence of a dual AV node physiology is 
considered to represent the substrate for reentry. However, 
use of the slow pathway as a target for ablation in patients 
without dual AV node pathways implies that it is part of the 
"normal" AV node. Dual AV node physiology can also occur 
in the absence of AV node reentry tachycardia (16), as initially 
described by Denes (17). Recent pathologic studies (18) have 
also shown the absence of differences in AV node structures in 
patients with or without evidence of dual AV node physiology. 
The presence of slow pathway potentials was described by 
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Haissaguerre etal. (19) in 80% of control patients without AV 
node reentry tachycardia. It is possible that these potentials do 
not represent activation of a slow AV node pathway; rather 
these could originate from atrial fibers joining the AV node 
from beneath the coronary sinus or fossa ovalis. The immedi- 
ate electrophysiologic effect occurring during radiofrequency 
delivery in sinus rhythm--induction f an active junctional 
rhythm with 1:1 VA conduction over the AV node--was in 
keeping with that commonly observed uring slow pathway 
ablation for AV junctional tachycardia. Similarly, the rapid 
increase in degree of AV ratio conduction after adiofrequency 
delivery during atrial flutter or tachycardia confirms that the 
ablated area plays a key role in allowing AV conduction at high 
rates. The AH interval remained unaffected by the procedure 
in all patients in whom it was measured. These observations 
describe the electrophysiologic effects expected as a result of 
ablation of the slow pathway. It should be stressed that none of 
the patients had clinical or electrophysiologic dual AV node 
physiology. Our data therefore support he concept hat the 
currently considered "slow pathway" is an atrial input with 
distinct conduction properties. This is probably part of the 
normal physiology of the AV node and is located in most cases 
in the posteroinferior atrial septum, anterior to the ostium of 
the coronary sinus. 
End points of the procedure. Prolongation of the Wenck- 
ebach cycle to 500 ms was a presumed end point because itwas 
thought that his would allow a marked reduction i  ventricular 
rate should atrial arrhythmia recur. Although the anterograde 
refractory period of the AV node and Wenckebach point were 
not systematically assessed after each radiofrequency delivery, 
it appeared clear that the modification of these conduction 
variables was a stepwise phenomenon, taking place gradually 
and requiring several pulses of energy at adjacent sites. Also, 
the degree of prolongation ofthe AV node effective refractory 
Figure 5. During an episode of typical atrial flutter with 2:1 atrioven- 
tricular (AV) conduction (first three cycles), delivery of radiofre- 
quency current to the slow AV node pathway inthis patient (Patient 1) 
causes a sudden i crease inAV ratio to 3:1 for two cycles, followed by 
a 7:1 and a 5:1 cycle; the AV ratio in the following beats remained 
stable at 4:1. Paper speed 50 mm/s. HRA = high right atrium. 
period and Wenckebach point required to achieve the modu- 
lation is greater than that observed after ablation of the slow 
pathway for the treatment ofAV junctional tachycardia. In the 
series published by Jazayeri et al. (9), the mean anterograde 
AV node refractory period increased from 245 to 280 ms and 
the Wenckebach cycle from 302 to 337 ms after slow pathway 
ablation. In the present series the values increased from 270 to 
390 ms and from 346 to 458 ms, respectively. In all cases the 
changes in AV conduction documented atthe termination of
the procedure reliably predicted ventricular rate during atrial 
fibrillation or flutter, as later confirmed in 11 of our patients 
during recurrence of spontaneous arrhythmia. 
When modulation was attempted uring atrial flutter or 
tachycardia, the increase in AV ratio was a reliable guide for 
defining the outcome of each energy application. Similar to 
that observed during sinus rhythm, attainment of a stable 
increase in AV ratio required multiple pulses. 
Therefore, AV node modulation seems to be a quantitative 
procedure that allows different levels of change in conduction 
variables to be obtained. The procedure does not appear to 
involve simple resection of a distinct "slow pathway"; rather, it 
implies possible extensive damage to the atrial tissue that 
conveys distinct functional inputs to the AV node, which may 
account for conduction at rapid rates. 
Failures of the procedure. Complete AV block was in- 
duced at the termination of the procedure in two patients 
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because of insufficient reduction in ventricular rate during 
atrial flutter in one patient and atrial fibrillation in the other. 
In both patients the AV block resulted from repeated attempts 
to reduce ventricular rate during flutter or fibrillation after 
extensive ablation. However, in one of these patients, 1:1 AV 
conduction ratio resumed 3 days later and remained stable 
during the follow-up period (2 months). From a physiologic 
point of view, these data mean that in at least 15% of the 
candidates for AV node modulation, ablation of the slow 
pathway or "posteroinferior right atrial input" is ineffective. It
is possible that, in these patients, other inputs, from the 
anterior septum or from the left side, may sustain conduction 
to the AV node at high rate; their electrophysiologic charac- 
terization may be helpful for achieving modulation i patients 
in whom the approach described herein failed. 
Results were similar when ablation was performed uring 
sinus rhythm, atrial flutter or fibrillation. However, the higher 
incidence of complete AV block that occurred uring atrial 
fibrillation or flutter suggests hat the procedure isbetter done 
in sinus rhythm, when a precise recording of the potential for 
the ablation site is possible. When ablation is performed 
during atrial flutter or atrial fibrillation, the location of the 
ablation target is guided by "anatomic" landmarks only and is 
less precise. Furthermore, monitoring of junctional rhythm and 
retrograde VA conduction during energy delivery is helpful in 
avoiding permanent AV block and can be recognized clearly 
only during sinus rhythm (10,11). 
Conclusions. Modulation of AV node conduction can be 
proposed as an alternative toHis bundle ablation for control of 
drug-refractory paroxysmal atrial fibrillation or flutter not 
amenable to direct atrial ablation. Furthermore, it can be 
performed as in addition to atrial ablation for typical atrial 
flutter with the goal of reducing the ventricular rate in the case 
of recurrence. The degree of modification of AV node con- 
duction variables can be measured after the procedure and 
remains table during the follow-up period. The failure rate of 
the procedure was 15% in the study patients. Prompt recogni- 
tion of failure can guide the clinician's decision of whether to 
perform a His bundle ablation without resorting to an addi- 
tional procedure. It should be emphasized that modulation of 
the AV node, because it does not prevent recurrence of atrial 
fibrillation, does not obviate the need for anticoagulation. 
Although the published ata are promising, the long-term safety 
and effectiveness of the technique described herein require 
confirmation i a larger series with a longer follow-up eriod. 
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